Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 12.92M
June 30, 2026 1.104M
March 31, 2026 -2.714M
December 31, 2025 3.47M
September 30, 2025 -17.82M
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.60M
June 30, 2024 5.911M
March 31, 2024 -2.73M
December 31, 2023 -3.651M
September 30, 2023 0.00
June 30, 2023 2.723M
March 31, 2023 0.40M
December 31, 2022 2.66M
September 30, 2022 4.442M
June 30, 2022 9.172M
March 31, 2022 20.18M
December 31, 2021 -4.439M
September 30, 2021 -6.652M
June 30, 2021 2.393M
March 31, 2021 -17.42M
December 31, 2020 5.775M
September 30, 2020 -1.214M
Date Value
June 30, 2020 6.928M
March 31, 2020 22.65M
December 31, 2019 6.889M
September 30, 2019 -33.21M
June 30, 2019 -10.62M
March 31, 2019 0.371M
December 31, 2018 -11.96M
September 30, 2018 10.71M
June 30, 2018 -9.428M
March 31, 2018 -0.203M
December 31, 2017 -7.475M
September 30, 2017 -0.534M
June 30, 2017 -1.425M
March 31, 2017 -0.536M
December 31, 2016 -1.837M
September 30, 2016 -0.578M
June 30, 2016 0.609M
March 31, 2016 3.615M
December 31, 2015 3.379M
September 30, 2015 5.801M
June 30, 2015 -0.463M
March 31, 2015 -0.514M
December 31, 2014 -0.765M
September 30, 2014 -3.552M
June 30, 2014 -0.217M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Relmada Therapeutics, Inc. 6.954M
Journey Medical Corp. 0.00
ANI Pharmaceuticals, Inc. -13.50M
Corcept Therapeutics, Inc. -131.99M
Veru, Inc. 1.802M